Clinical Trial Update: Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating an adaptive neoadjuvant therapy approach to maximize surgical resection rates in pancreatic adenocarcinoma. The trial is sponsored by t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Snippet

Sponsor: University of Cincinnati | Conditions: Pancreas Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING